Alphatec Holdings Inc. (ATEC), a medical technology company with a market capitalization of $1.56 billion, delivered a robust performance in Q2 2025, exceeding both earnings per share (EPS) and revenue forecasts. The company reported an EPS of $0.02, significantly outperforming the anticipated -$0.04, marking a 150% surprise. Revenue reached $185.54 million, surpassing the expected $178.8 million by 3.77%.
Alphatec increased its full-year revenue guidance to $742 million, with surgical revenue expected to reach $666 million. The company is targeting an 18% adjusted EBITDA margin by 2027, with expectations of positive free cash flow for the full year 2025. The upcoming robotic system launch in early 2026 is anticipated to drive further growth.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.